Literature DB >> 12006315

Follow up studies in rheumatoid arthritis.

R Landewé1, D van der Heijde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12006315      PMCID： PMC1754110          DOI： 10.1136/ard.61.6.479

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  20 in total

1.  Causal inference in a clinical trial: a comparative example.

Authors:  D F Heitjan
Journal:  Control Clin Trials       Date:  1999-08

2.  Does cyclosporin A cause cancer?

Authors:  R B Landewé; B E van den Borne; F C Breedveld; B A Dijkmans
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

3.  Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate.

Authors:  O Sander; G Herborn; E Bock; R Rau
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

4.  Long-term followup of patients receiving combined therapy with cyclosporine and methotrexate.

Authors:  M A González-Gay; R Blanco; C García-Porrúa; D Ibáñez; M Vázquez-Caruncho; J Sánchez-Bursón; J L Marenco
Journal:  Arthritis Rheum       Date:  1998-09

5.  Different statistical models to analyze epidemiological observational longitudinal data: an example from the Amsterdam Growth and Health Study.

Authors:  J W Twisk
Journal:  Int J Sports Med       Date:  1997-07       Impact factor: 3.118

6.  Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis.

Authors:  M J Plant; A L Williams; M M O'Sullivan; P A Lewis; E C Coles; J D Jessop
Journal:  Arthritis Rheum       Date:  2000-07

7.  Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group.

Authors:  C M Stein; T Pincus; D Yocum; P Tugwell; G Wells; O Gluck; G Kraag; H Torley; J Tesser; R McKendry; R H Brooks
Journal:  Arthritis Rheum       Date:  1997-10

8.  Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time.

Authors:  K W Drossaers-Bakker; M de Buck; D van Zeben; A H Zwinderman; F C Breedveld; J M Hazes
Journal:  Arthritis Rheum       Date:  1999-09

9.  A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis.

Authors:  J D Jessop; M M O'Sullivan; P A Lewis; L A Williams; J P Camilleri; M J Plant; E C Coles
Journal:  Br J Rheumatol       Date:  1998-09

10.  No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.

Authors:  B E van den Borne; R B Landewé; I Houkes; F Schild; P C van der Heyden; J M Hazes; J P Vandenbroucke; A H Zwinderman; H S Goei The; F C Breedveld; H J Bernelot Moens; P M Kluin; B A Dijkmans
Journal:  Arthritis Rheum       Date:  1998-11
View more
  4 in total

Review 1.  Appropriate and effective management of rheumatoid arthritis.

Authors:  F C Breedveld; J R Kalden
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

2.  Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.

Authors:  Piero Ruscitti; Paola Cipriani; Francesco Masedu; Daniela Iacono; Francesco Ciccia; Vasiliki Liakouli; Giuliana Guggino; Francesco Carubbi; Onorina Berardicurti; Paola Di Benedetto; Marco Valenti; Giovanni Triolo; Gabriele Valentini; Roberto Giacomelli
Journal:  BMC Med       Date:  2016-12-01       Impact factor: 8.775

3.  The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile.

Authors:  Piero Ruscitti; Antonio Barile; Onorina Berardicurti; Roberto Giacomelli; Paola Cipriani; Sonia Iafrate; Paola Di Benedetto; Antonio Vitale; Francesco Caso; Luisa Costa; Federico Bruno; Francesco Ursini; Luca Navarini; Federica Sensini; Raffaele Scarpa; Bruno Frediani; Luca Cantarini; Carlo Masciocchi
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

4.  Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study.

Authors:  Désirée van der Heijde; Vibeke Strand; Yoshiya Tanaka; Edward Keystone; Joel Kremer; Cristiano A F Zerbini; Mario H Cardiel; Stanley Cohen; Peter Nash; Yeong-Wook Song; Dana Tegzová; David Gruben; Gene Wallenstein; Carol A Connell; Roy Fleischmann
Journal:  Arthritis Rheumatol       Date:  2019-04-24       Impact factor: 10.995
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.